Narayana Health Ltd. is implementing a comprehensive strategy to improve margins in its UK business through targeted operational improvements. According to Sandhya J, group chief financial officer, the company plans to increase the share of private-paying patients while utilizing spare capacity at existing facilities and deploying technology-led efficiency measures. The strategy comes months after the hospital chain entered the UK market through the acquisition of Practice Plus Group hospitals in November FY26. As per latest reports, the company sees significant room for margin improvement in its newly acquired UK business, with current EBITDA margins of around 10-10.5% compared to competitors operating in the 'high teens', indicating substantial upside potential over time. Recent earnings call discussions reveal that EBITDA margins have increased from 7-8% at acquisition to 10% in Q4, though the company acknowledges this represents a normalized baseline rather than peak performance, with full margin improvement expected over the next few quarters as transition costs stabilize.
Narayana Health's UK business currently operates 13 facilities with 330 operational beds and contributed ₹80.90 crore in revenue during the March quarter and ₹129.92 crore since the acquisition date of November 6, 2025, as reported in the company's earnings release. The business derives 93% of payers from the National Health Service, providing stable revenue visibility, though reimbursement rates are typically lower than treatments funded through private insurance or self-paying patients. The company plans to increase private-pay patients while retaining its large NHS-linked revenue base to achieve margin improvement. Recent earnings call discussions indicate that private pay revenue has increased from 7% at acquisition to current levels, with the company targeting a realistic two-year target for further private patient growth. The UK business operates under a 150 million pound seven-year loan structure, with current cash flows sufficient to service the debt despite net negative profit numbers due to amortization of expenses.
The company is implementing technology-driven interventions to improve operational efficiency in UK operations. As reported by NDTV Profit, Sandhya J stated that the company is looking at tech-driven interventions to improve operating efficiency and lower costs. This approach aligns with the company's broader strategy to enhance operational leverage across its global operations, with recent developments showing successful integration of pharmacy services within hospital and clinic operations, providing value-added services like home delivery. The company's radiology department is completely powered by AI, with radiologists using software that implements image guidance AI for diagnoses. Advanced AI applications include AI-powered medical records systems that provide single source of truth for patient data, enabling doctors to identify undiagnosed diseases and conduct research on patient populations. The company's ATMA system has unlocked significant efficiencies by improving medical record management and patient throughput, with robotic cardiac surgeries reaching 100 cases per month at the Bangalore facility, significantly outpacing competitors who typically handle 1-2 cases annually.
Narayana Health has committed around ₹3,000 crore towards expansion projects in India that will add around 2,000 beds across greenfield and built-to-suit facilities. According to the company's investor presentation, most of these projects are expected to become operational in FY28 and FY29, with one project set to go live next month. The company expects continued organic growth in India, supported by operational efficiencies, higher-value bed configurations and expansion in integrated care and insurance businesses. Recent developments show significant growth in Bangalore facility, particularly in high-end surgeries such as robotic cardiac surgeries and pediatric bone marrow transplants, with clinics becoming important channels for domestic patient access and long-term customer relationships. The ARPP (Average Revenue Per Patient) for Bangalore cluster has reached ₹2.5 lakh, representing one of the highest figures in the hospital industry, driven by complex procedures like 100 robotic cardiac surgeries per month and advanced transplant work. The company maintains 60-65% occupancy rates while focusing on premium procedures that command higher realizations.
Narayana Health reported strong financial performance for Q4FY26, with consolidated revenue jumping nearly 76% year-on-year to ₹2,594 crore and net profit rising over 16% YoY to ₹228 crore. EBITDA increased more than 40% to ₹539 crore, while for the full year, revenue climbed 42% to ₹7,806 crore and profit rose marginally to ₹810.5 crore. However, annual EBITDA margins moderated to 22% from 25% a year earlier, reflecting the impact of investments in newer businesses and the lower-margin UK operations. The company has maintained strong margins in its India hospital business with potential for further margin expansion due to ongoing efficiency improvements, though faces challenges in its insurance business experiencing losses with no clear timeline for breakeven. Recent earnings call discussions reveal that margins have expanded from 21.5% to 25.1% in India operations, with management confident that gains are sustainable despite current headwinds including volatile crude oil and dollar costs. The company expects to maintain margins at 20% at the console level going forward, with normalized EBITDA margins around 22% after accounting for one-time acquisition costs related to the UK business.
